Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "dyskinetic-cerebral-palsy"

1 News Found

Neurocrine’s Valbenazine fails to show benefit in largest dyskinetic cerebral palsy trial
Clinical Trials | December 24, 2025

Neurocrine’s Valbenazine fails to show benefit in largest dyskinetic cerebral palsy trial

Adverse events were consistent with valbenazine’s established safety profile